167 related articles for article (PubMed ID: 34392916)
1. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Howard BA; Wong TZ
Radiol Clin North Am; 2021 Sep; 59(5):737-753. PubMed ID: 34392916
[TBL] [Abstract][Full Text] [Related]
2. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
3. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Banks KP; Song WS
Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
[TBL] [Abstract][Full Text] [Related]
4. [Roles of F-18 FDG PET or PET/CT for the evaluation of gastrointestinal malignancies].
Yun M; Kim BI
Korean J Gastroenterol; 2006 Dec; 48(6):378-87. PubMed ID: 17189920
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of gastrointestinal tract malignancies using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG)].
Kato H; Sohda M; Kuwano H
Nihon Shokakibyo Gakkai Zasshi; 2004 Dec; 101(12):1292-301. PubMed ID: 15651391
[No Abstract] [Full Text] [Related]
6. Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Tind S; Vestergaard S; Farahani ZA; Hess S
Minerva Chir; 2017 Oct; 72(5):397-415. PubMed ID: 28565893
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography for the diagnosis and management of patients with gastrointestinal malignancies.
Saga T; Nakamoto Y; Higashi T; Yoshikawa K
Gastrointest Endosc Clin N Am; 2008 Jul; 18(3):479-93, ix. PubMed ID: 18674698
[TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies.
Gnanasegaran G; Agrawal K; Wan S
PET Clin; 2022 Jul; 17(3):369-388. PubMed ID: 35717098
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging.
Caresia Aroztegui AP; García Vicente AM; Alvarez Ruiz S; Delgado Bolton RC; Orcajo Rincon J; Garcia Garzon JR; de Arcocha Torres M; Garcia-Velloso MJ;
Tumour Biol; 2017 Oct; 39(10):1010428317728285. PubMed ID: 29025377
[TBL] [Abstract][Full Text] [Related]
10. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
11. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
12. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
13. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
14. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
15. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging.
Sugrue G; Nguyen BD
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27530882
[No Abstract] [Full Text] [Related]
17. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
19. PET Imaging for Head and Neck Cancers.
Marcus C; Sheikhbahaei S; Shivamurthy VKN; Avey G; Subramaniam RM
Radiol Clin North Am; 2021 Sep; 59(5):773-788. PubMed ID: 34392918
[TBL] [Abstract][Full Text] [Related]
20. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
